Logo

Imbio

Imbio provides imaging analysis for patients suffering from both acute and chronic diseases. For example, Lung Density Analysis™ and Lung Texture Analysis™, apply Imbio's fully automated technology to chest CT studies to generate rich visual maps of a patient's lungs; accompanying reports provide detailed data on the type and extent of density and texture abnormalities found in the images. Clinicians can quickly visualize a patient's lung density and/or texture to support diagnosis and treatment decisions for a variety of patient conditions including COPD/emphysema and fibrotic disease.

Company specifications

General
Company name Imbio
Founded 2012
Head office Minneapolis, United States
Website http://www.imbio.com
Contact info@imbio.com

Products by this company

Logo
Subspeciality: Chest
Modality: CT

Lung density quantification, abnormal lung region mapping, report generation

Lung Density Analysis™ applies big data analysis to paired inspiratory / expiratory chest CT studies to provide visualization and quantification of lung regions with abnormal tissue density. ...

CE:
Class IIa
Logo
FDA:
Class II
Logo
Information source:
Vendor
Certification verified:
No
Logo
Subspeciality: Chest
Modality: CT

fibrotic condition identification, percentage of lung affected, volume quantification, report ...

Lung Texture Analysis ™ from Imbio automatically applies computer vision to transform a standard chest CT into a map of the lung textures to identify ILD’s and other fibrotic conditions (normal, ...

CE:
Class IIa
Logo
FDA:
Logo
Information source:
Vendor
Certification verified:
No
Logo
Subspeciality: Cardiac, Chest
Modality: CT

ventricle diameter quantification, RV/LV ratio

RV/LV ratio can inform a physician on the severity of a Pulmonary Embolism by comparing the diameters of the right and left ventricles of the heart.

CE:
Class IIa
Logo
FDA:
Logo
Information source:
Vendor
Certification verified:
No